Literature DB >> 27046292

Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.

Hyeyeon Chang1, Hye Lim Lee1, Minju Yeo1, Ji Seon Kim1, Dong-Ick Shin1, Sang-Soo Lee1, Sung-Hyun Lee2.   

Abstract

Human papillomavirus (HPV) vaccine is widely used to prevent cervical cancer caused by certain types of HPV in girls and young women. Demyelinating disorders within months following HPV innoculation have been reported, but the causal link between HPV vaccination and the onset of demyelinating disorders have not been certain. We report a case of neuromyelitis optica spectrum disorder (NMOSD) that was noteworthy because optic neuritis (ON) occurred in a very close temporal association with both the first and second HPV vaccinations, which might suggest an association between HPV vaccination and the development of NMO-IgG and recurrent ON. This emphasizes the necessity for continuing surveillance for adverse events after HPV vaccination.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune demyelinating disease; Human papillomavirus vaccine; Neuromyelitis optica; Optic neuritis

Mesh:

Substances:

Year:  2016        PMID: 27046292     DOI: 10.1016/j.clineuro.2016.03.023

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Simultaneous Bilateral Optic Neuritis Following Human Papillomavirus Vaccination in a Young Child.

Authors:  Ngu Dau Bing Michael; Tengku Norina Tuan Jaffar; Adil Hussein; Wan-Hazabbah Wan Hitam
Journal:  Cureus       Date:  2018-09-24

2.  Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.

Authors:  Jung Ran; Ji-Young Yang; Ji-Ho Lee; Hye-Jun Kim; Jun-Yeong Choi; Ju-Young Shin
Journal:  Int J Clin Pharm       Date:  2019-07-16

Review 3.  Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.

Authors:  Maryam Dadar; Sandip Chakraborty; Kuldeep Dhama; Minakshi Prasad; Rekha Khandia; Sameer Hassan; Ashok Munjal; Ruchi Tiwari; Kumaragurubaran Karthik; Deepak Kumar; Hafiz M N Iqbal; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.